ImpriMed Launches New Diagnostic Services for Canine Lymphoma
19 oct. 2021 08h00 HE
|
ImpriMed, Inc.
PALO ALTO, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- ImpriMed, Inc., a leading functional precision medicine company in veterinary oncology that provides a personalized drug response profiling...